Filing Details

Accession Number:
0001628280-25-016057
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-01 21:53:53
Reporting Period:
2025-03-20
Filing Date:
2025-04-01
Accepted Time:
2025-04-01 21:53:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098146 Patriot National Bancorp Inc PNBK National Commercial Banks (6021) 061559137
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504590 Steven Sugarman C/O Patriot National Bancorp, Inc.
900 Bedford Street
Stamford CT 06901
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-20 7,019,978 $0.75 7,019,978 No 4 P Indirect By Steven and Ainslie Sugarman Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Steven and Ainslie Sugarman Living Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Acquisiton 2025-03-20 19,167 $0.00 1,533,333 $0.75
Common Stock Series A Preferred Stock Acquisiton 2025-03-20 5,833 $0.00 466,667 $0.75
Common Stock Restricted Stock Units Acquisiton 2025-03-20 4,049,593 $0.00 4,049,593 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,167 2025-03-20 No 4 P Indirect
25,000 2025-03-20 No 4 J Indirect
4,049,593 2026-03-20 2026-03-20 No 4 A Direct
Footnotes
  1. On March 20, 2025, Patriot National Bancorp, Inc. (the Issuer) completed its private placement of: (i) shares of common stock, par value $0.01 per share (Common Stock), at a purchase price of $0.75 per share, and (ii) shares of a new series of preferred stock, no par value per share (the Series A Preferred Stock), with a liquidation preference of $60 per share (the Private Placement). Steven and Ainslie Sugarman Living Trust (the Trust) purchased, as part of the Private Placement: (i) 7,019,978 shares of Common Stock and (ii) 19,167 shares of Series A Preferred Stock, subject to the limitation that no investor in the Private Placement has the right to become the beneficial owner (as determined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act)) of more than 9.99% of the voting securities issued and outstanding of the Issuer.
  2. The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.
  3. Series A Preferred Stock is perpetual and therefore has no expiration date.
  4. The Trust was issued 5,833 shares of Series A Preferred Stock convertible into 466,667 shares of Common Stock at the pre-funded conversion price of $0.75 per share, as a reimbursement of the Reporting Persons legal fees and expenses relating to the Private Placement, subject to the limitation that the Reporting Person does not have the right to become, directly or indirectly, the beneficial owner of more than 9.99% of the number of shares of the voting securities issued and outstanding of the Issuer.
  5. Restricted Stock Units (RSUs) were granted pursuant to the Employment Agreement between the Reporting Person and the Issuer, effective as of March 20, 2025. RSUs vest in 12 equal monthly installments commencing on March 20, 2025 and expires on March 20, 2026. Vested RSUs represent the right to be settled on the date of the expiration, provided that if: (i) the 2025 Omnibus Equity Incentive Plan (the Plan) has not been approved by its shareholders, each vested RSU will be settled in cash equal to the fair market value of one share of Common Stock as of March 20, 2026; or (ii) the Plan has been approved by the shareholders of the Issuer, each vested RSU will be settled in one share of Common Stock and with no cash settlement option, subject to the limitation that the Reporting Person does not have the right to become the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.99% of shares of the voting securities issued and outstanding of the Issuer.